How does inflammation contribute to pulmonary hypertension?
作者信息
Kumar Rahul, Graham Brian
机构信息
Program in Translational Lung Research, Dept of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO, USA.
Program in Translational Lung Research, Dept of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, CO, USA
出版信息
Eur Respir J. 2018 Jan 25;51(1). doi: 10.1183/13993003.02403-2017. Print 2018 Jan.
Abstract
摘要
相似文献
1
How does inflammation contribute to pulmonary hypertension?
Eur Respir J. 2018 Jan 25;51(1). doi: 10.1183/13993003.02403-2017. Print 2018 Jan.
2
The histologic structure of the pulmonary trunk in patients with "primary" pulmonary hypertension.
Am Heart J. 1963 Feb;65:230-6. doi: 10.1016/0002-8703(63)90155-8.
3
Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1504-1506. doi: 10.1161/ATVBAHA.119.312969. Epub 2019 Jul 24.
4
Full Circle on Pulmonary Flow Dynamics in Pulmonary Arterial Hypertension.
JACC Cardiovasc Imaging. 2017 Oct;10(10 Pt B):1278-1280. doi: 10.1016/j.jcmg.2016.12.022.
5
[The mechanisms of inflammation in pulmonary arterial hypertension.].
Zhonghua Jie He He Hu Xi Za Zhi. 2009 Nov;32(11):862-5.
6
Transthoracic Pulmonary Artery Denervation.
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):979-981. doi: 10.1161/ATVBAHA.119.312591.
7
Do BRD(4)S of a Feather Flock Together? How an Inflammation-Driven Epigenetic Regulator May Link Pulmonary Hypertension and Coronary Artery Disease.
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1428-1430. doi: 10.1161/ATVBAHA.117.309632.
8
Pulmonary arterial capacitance index is a strong predictor for adverse outcome in children with idiopathic and heritable pulmonary arterial hypertension: methodological issues to avoid misinterpretation.
J Pediatr. 2017 May;184:239-240. doi: 10.1016/j.jpeds.2017.01.030.
9
Pulmonary arterial hypertension and the Enigma code of smouldering inflammation.
Eur Respir J. 2016 Aug;48(2):305-7. doi: 10.1183/13993003.00996-2016.
10
Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
Eur Respir J. 2019 Mar 28;53(3). doi: 10.1183/13993003.00005-2019. Print 2019 Mar.
引用本文的文献
1
Vascular Remodeling: The Multicellular Mechanisms of Pulmonary Hypertension.
Int J Mol Sci. 2025 Apr 30;26(9):4265. doi: 10.3390/ijms26094265.
2
Assessing the causality between pulmonary arterial hypertension and cancer: insights from Mendelian randomization.
Discov Oncol. 2024 Dec 21;15(1):821. doi: 10.1007/s12672-024-01727-1.
3
EnFUSiasm for Healing: Ultrasound Neuromodulation in PAH.
Circ Res. 2024 Jun 21;135(1):57-59. doi: 10.1161/CIRCRESAHA.124.324791. Epub 2024 Jun 20.
4
Relationship Between Pulmonary Artery Pressure and Inflammation Parameters.
Cureus. 2024 Jan 17;16(1):e52427. doi: 10.7759/cureus.52427. eCollection 2024 Jan.
5
A very rare cause of pre-capillary pulmonary hypertension: The PAMI syndrome.
Pulm Circ. 2023 Oct 22;13(4):e12300. doi: 10.1002/pul2.12300. eCollection 2023 Oct.
6
Single-cell analysis of peripheral blood from high-altitude pulmonary hypertension patients identifies a distinct monocyte phenotype.
Nat Commun. 2023 Mar 31;14(1):1820. doi: 10.1038/s41467-023-37527-4.
7
Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice.
Rev Cardiovasc Med. 2022;23(11). doi: 10.31083/j.rcm2311378. Epub 2022 Nov 9.
8
Pulmonary Vascular Remodeling in Pulmonary Hypertension.
J Pers Med. 2023 Feb 19;13(2):366. doi: 10.3390/jpm13020366.
9
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.
Circulation. 2022 Oct 4;146(14):1033-1045. doi: 10.1161/CIRCULATIONAHA.121.056719. Epub 2022 Aug 25.
10
Treating Inflammation Associated with Pulmonary Hypertension: An Overview of the Literature.
Int J Gen Med. 2022 Feb 3;15:1075-1083. doi: 10.2147/IJGM.S295463. eCollection 2022.
本文引用的文献
1
The inflammatory cell landscape in the lungs of patients with idiopathic pulmonary arterial hypertension.
Eur Respir J. 2018 Jan 25;51(1). doi: 10.1183/13993003.01214-2017. Print 2018 Jan.
2
Lung cancer-associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell-immune cell cross-talk.
Sci Transl Med. 2017 Nov 15;9(416). doi: 10.1126/scitranslmed.aai9048.
3
Origin and production of inflammatory perivascular macrophages in pulmonary hypertension.
Cytokine. 2017 Dec;100:11-15. doi: 10.1016/j.cyto.2017.08.015. Epub 2017 Aug 30.
4
TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension.
Nat Commun. 2017 May 30;8:15494. doi: 10.1038/ncomms15494.
5
The Importance of Dendritic Cells in Maintaining Immune Tolerance.
J Immunol. 2017 Mar 15;198(6):2223-2231. doi: 10.4049/jimmunol.1601629.
6
Three Unique Interstitial Macrophages in the Murine Lung at Steady State.
Am J Respir Cell Mol Biol. 2017 Jul;57(1):66-76. doi: 10.1165/rcmb.2016-0361OC.
7
The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol. 2017 May 1;312(5):L710-L721. doi: 10.1152/ajplung.00311.2016. Epub 2017 Feb 24.
8
Central role of T helper 17 cells in chronic hypoxia-induced pulmonary hypertension.
Am J Physiol Lung Cell Mol Physiol. 2017 May 1;312(5):L609-L624. doi: 10.1152/ajplung.00531.2016. Epub 2017 Feb 17.
9
Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension.
J Pharmacol Exp Ther. 2017 Feb;360(2):267-279. doi: 10.1124/jpet.116.237933. Epub 2016 Dec 7.
10
The Causal Role of IL-4 and IL-13 in Schistosoma mansoni Pulmonary Hypertension.
Am J Respir Crit Care Med. 2015 Oct 15;192(8):998-1008. doi: 10.1164/rccm.201410-1820OC.
Zotero 插件